
Add to Cart
Serum amyloid A (SAA) is an acute phase reactive protein secreted by the liver, which has a trace content in the blood of healthy people. When virus or bacterial infection occurs, SAA will begin to increase significantly within 3 to 6 hours, and it will increase hundreds or even thousands of times in acute state. The half-life of SAA is short and decreases rapidly during the recovery of diseases more sensitive than CRP. Combined detection of SAA and CRP can better distinguish the types of infection and improve the diagnostic efficiency of virus infection.
Detection range | sample size | Sample type | Test time |
5~200mg/L | 5μl | Whole blood / serum / plasma | 3min |
Dynamic monitoring
| Sensitive index of virus infection | SAA is more sensitive than CRP when infected with virus. Combined detection of CRP and SAA is conducive to early identification of infectious diseases. |
Indicators of graft rejection | SAA is one of the first indicators to detect rejection, which can be used as a sensitive marker to detect rejection patients early. | |
The monitoring index of tumor invasion and metastasis | SAA value is closely related to tumor activity, disease status, malignancy, invasion and metastasis, and can be used as one of the dynamic monitoring indicators. | |
Predictors of cardiovascular events | Therefore, SAA can be used as a predictor of cardiovascular events and prognosis. | |
Diagnosis index of AA amyloid disease | SAA is a precursor of AA and is very important for the etiology. Highly concentrated SAA can be used as an indicator of treatment and prognosis. |
Index | CRP | SAA |
Time of discovery | 1930 | 1976 |
Clinical features | Bacterial infection increased 30% of the virus infection increased | Viral infections have increased significantly. |
Peak time | Rising period: 4-6 hours Platform period: 24-48 hours Half life: 18 hours | Rising period: 3-6 hours Platform period: 5-6 hours Half life: 50 minutes |
Examination room, emergency room, intensive care unit, Pediatrics / neonatology, respiratory department, surgery, hematology department, rheumatology department, Immunology Department, oncology department, nephrology department, etc.
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.